Patient Reported Outcome Measure for Vascular Malformation ("PROVAM") Questionnaire

C16497
Technology No. C16497

**Once a license request has been received and approved, JHU will send a license for execution via DocuSign to the Requestor's or Authorized Representative's email. After full execution of the license, the technology materials will be made available for download via this portal.**


Product Description

PROVAM was developed to assess symptoms, functional limitations, and social/emotional effects experienced by patients with low-flow vascular malformations (VMs).  The 30-item instrument assesses the domains of pain, emotional/social well-being, functional impact, and treatment satisfaction. Two additional items assess ease of understanding and relevance.  PROVAM is responsive to improvement after treatment and may be useful to assess health-related quality of life in patients treated for VMs.

Non-exclusive Academic or Non-Profit Research License

Term: 3 years

Free of charge

Non-exclusive License for Clinical Trials
Licensing Fee is $3,000 per 100 Trial Participants

Term: 3 years

Options available:
From $3,000.00 excl. TAX